The following sections of the Standards of Medical Care in Diabetes—2021 have been updated to include the latest evidence-based recommendations from the American Diabetes Association: Classification and Diagnosis of Diabetes, Cardiovascular Disease and Risk Management, and Microvascular Complications and Foot Care. To access the updates, please visit https://care.diabetesjournals.org/living-standards.

Filled with practical tips, this series of short videos showcases leading experts sharing pragmatic strategies for overcoming therapeutic inertia in your practice today. ADA encourages viewers to try these approaches out for themselves and to share them with other clinicians within their networks. The series is hosted by Dr. Neil Skolnik and features guests such as ADA's Chief Scientific and Medical Officer Dr. Robert Gabbay; Dr. Kamlesh Khunti, a researcher from University of Leicester, U.K.; and others. To view the full series, visit professional.diabetes.org/meetings/practice-pearls-video-series.

In a series of short videos now available on the Clinical Diabetes website, Drs. Vivian Fonseca, Minisha Sood, and Rodolfo Galindo discuss the pathophysiological changes that occur during the progression of type 2 diabetes, with a particular focus on the key role of declining β-cell function, as well as the clinical characteristics—long duration of type 2 diabetes and A1C ≥9%—that are indicative of diminishing β-cell function. An executive summary and videos of the full panel can be found at clinical.diabetesjournals.org/content/combination-injectable-therapy.

In the third and final episode of this special series (supported by an unrestricted educational grant from the Division of Cardiovascular & Metabolic Diseases of U.S. Medical at AstraZeneca Pharmaceuticals, LP), Drs. Neil Skolnik and John Russell discuss the most recent large-scale trials that have focused on the cardiovascular effects associated with SGLT2 inhibitors, how the outcomes of those trials have influenced the latest treatment guidelines related to cardiovascular disease and risk management in patients with type 2 diabetes, and how SGLT2 inhibitors should be sequenced in the treatment of patients with type 2 diabetes and cardiovascular complications. To listen to the complete series, visit diabetesjournals.org/content/sglt2i-podcasts.

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit care.diabetesjournals.org/collection/diabetes-and-COVID19.

Join ADA's Chief Scientific and Medical Officer, Robert Gabbay, MD, PhD, for a presentation on the key updates and highlights from the Standards of Medical Care in Diabetes—2021. To access the webcast, please visit professional.diabetes.org/SOC.

© 2021 by the American Diabetes Association
2021
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.